Agonists of proteinase‐activated receptor‐2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3‐D collagen lattices

Proteinase‐activated receptor‐2 (PAR2) belongs to a novel subfamily of G‐protein‐coupled receptors with seven‐transmembrane domains. PAR2 can be activated by serine proteases such as trypsin, mast cell tryptase, and allergic or bacterial proteases. This receptor is expressed by various cells and seems to be crucially involved during inflammation and the immune response. As previously reported, human neutrophils express functional PAR2. However, the precise physiological role of PAR2 on human neutrophils and its implication in human diseases remain unclear. We demonstrate that PAR2 agonist‐stimulated human neutrophils show significantly enhanced migration in 3‐D collagen lattices. PAR2 agonist stimulation also induced down‐regulation of L‐selectin display and up‐regulation of membrane‐activated complex‐1 very late antigen‐4 integrin expression on the neutrophil cell surface. Moreover, PAR2 stimulation results in an increased secretion of the cytokines interleukin (IL)‐1β, IL‐8, and IL‐6 by human neutrophils. These data indicate that PAR2 plays an important role in human neutrophil activation and may affect key neutrophil functions by regulating cell motility in the extracellular matrix, selectin shedding, and up‐regulation of integrin expression and by stimulating the secretion of inflammatory mediators. Thus, PAR2 may represent a potential therapeutic target for the treatment of diseases involving activated neutrophils.

[1]  T. Luger,et al.  Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. , 2008, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  T. Luger,et al.  Proinflammatory role of proteinase‐activated receptor‐2 in humans and mice during cutaneous inflammation in vivo , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  J. Caamaño,et al.  Fibrinogen‐CD11b/CD18 interaction activates the NF‐κB pathway and delays apoptosis in human neutrophils , 2003, European journal of immunology.

[4]  P. Thompson,et al.  House Dust Mite Allergens Induce Proinflammatory Cytokines from Respiratory Epithelial Cells: The Cysteine Protease Allergen, Der p 1, Activates Protease-Activated Receptor (PAR)-2 and Inactivates PAR-11 , 2002, The Journal of Immunology.

[5]  M. Lucas,et al.  Expression of thrombin receptors in endothelial cells and neutrophils from normal and preeclamptic pregnancies. , 2002, The Journal of clinical endocrinology and metabolism.

[6]  M. Hollenberg,et al.  International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors , 2002, Pharmacological Reviews.

[7]  A. García-Pardo,et al.  Adhesion to fibronectin via α4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo‐1 receptors , 2002, Clinical and experimental immunology.

[8]  W. MacNee,et al.  Potential role of IL‐8, platelet‐activating factor and TNF‐α in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis , 2002, European journal of immunology.

[9]  H. Kita,et al.  Trypsin Induces Activation and Inflammatory Mediator Release from Human Eosinophils Through Protease-Activated Receptor-21 , 2001, The Journal of Immunology.

[10]  T. Yoshimura,et al.  Discoidin domain receptor 1 isoform‐a (DDRla) promotes migration of leukocytes in three‐dimensional collagen lattices , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  M. Stacey,et al.  Interaction of Mite Allergens Der P3 and Der P9 with Protease-Activated Receptor-2 Expressed by Lung Epithelial Cells1 , 2001, The Journal of Immunology.

[12]  A. Lechtermann,et al.  Decoupling of Intracellular Calcium Signaling in Granulocytes After Exhaustive Exercise , 2001, International journal of sports medicine.

[13]  J. Moffatt,et al.  Protease-activated receptor-2 (PAR2) in the airways. , 2001, Pulmonary pharmacology & therapeutics.

[14]  Klaus Ley,et al.  L-Selectin Shedding Regulates Leukocyte Recruitment , 2001, The Journal of experimental medicine.

[15]  C. F. Fernandez-del Castillo,et al.  Expression of the Adhesion Molecules Mac-1 and l-Selectin on Neutrophils in Acute Pancreatitis is Protease- and Complement-Dependent , 2001, Annals of surgery.

[16]  M. Hollenberg,et al.  A Polymorphic Protease-activated Receptor 2 (PAR2) Displaying Reduced Sensitivity to Trypsin and Differential Responses to PAR Agonists* , 2000, The Journal of Biological Chemistry.

[17]  D. Bernstein,et al.  Delayed Onset of Inflammation in Protease-Activated Receptor-2-Deficient Mice1 , 2000, The Journal of Immunology.

[18]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[19]  R. Roth,et al.  Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. , 2000, Pharmacological reviews.

[20]  P. Rieu,et al.  Neutrophils: Molecules, Functions and Pathophysiological Aspects , 2000, Laboratory Investigation.

[21]  E. Bröcker,et al.  Migration of dendritic cells within 3‐D collagen lattices is dependent on tissue origin, state of maturation, and matrix structure and is maintained by proinflammatory cytokines , 2000, Journal of leukocyte biology.

[22]  J. Wallace,et al.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.

[23]  M. Hollenberg,et al.  Proteinase-activated receptors (PARs): activation of PAR1 and PAR2 by a proteolytic fragment of the neuronal growth associated protein B-50/GAP-43. , 1999, Canadian journal of physiology and pharmacology.

[24]  N. Vergnolle Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. , 1999, Journal of immunology.

[25]  H. Simms,et al.  IL-1beta stimulation induces paracrine regulation of PMN function and apoptosis. , 1999, Shock.

[26]  M. Hollenberg,et al.  Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands. , 1999, The Journal of pharmacology and experimental therapeutics.

[27]  M. Steinhoff,et al.  Proteinase‐activated receptor‐2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase , 1999, Experimental dermatology.

[28]  Klaus Ley,et al.  Relevance of L-selectin Shedding for Leukocyte Rolling In Vivo , 1999, The Journal of experimental medicine.

[29]  G. Murphy,et al.  Tissue Inhibitor of Metalloproteinases-3 Inhibits Shedding of L-selectin from Leukocytes* , 1999, The Journal of Biological Chemistry.

[30]  M. Hollenberg,et al.  Endothelium‐dependent contractile actions of proteinase‐activated receptor‐2‐activating peptides in human umbilical vein: release of a contracting factor via a novel receptor , 1998, British journal of pharmacology.

[31]  K. Forsyth,et al.  Shedding of L-selectin and PECAM-1 and upregulation of Mac-1 and ICAM-1 on neutrophils in RSV bronchiolitis. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[32]  J. Potempa,et al.  Cleavage and activation of proteinase‐activated receptor‐2 on human neutrophils by gingipain‐R from Porphyromonas gingivalis , 1998, FEBS letters.

[33]  J. Wallace,et al.  Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Steinhoff,et al.  Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. , 1998, American journal of physiology. Cell physiology.

[35]  P. Friedl,et al.  Differential requirement of protein tyrosine kinases and protein kinase C in the regulation of T cell locomotion in three-dimensional collagen matrices. , 1997, Journal of immunology.

[36]  H. Richter,et al.  Endogenous trypsin receptors in Xenopus oocytes: linkage to internal calcium stores , 1997, Cellular and Molecular Life Sciences CMLS.

[37]  S. Edwards,et al.  Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. , 1997, Immunology today.

[38]  D. Granger,et al.  Soluble Selectins and ICAM-1 Modulate Neutrophil-Endothelial Adhesion and Diapedesis in Vitro , 1997, Inflammation.

[39]  P. Friedl,et al.  Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. , 1997, Cancer research.

[40]  F. Luscinskas,et al.  L-selectin shedding does not regulate human neutrophil attachment, rolling, or transmigration across human vascular endothelium in vitro. , 1997, Journal of immunology.

[41]  M. Macey,et al.  Proteinase-activated receptor-2: expression by human neutrophils. , 1997, Journal of cell science.

[42]  J. Hoxie,et al.  Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2* , 1997, The Journal of Biological Chemistry.

[43]  F. Maxfield,et al.  Dynamic imaging of neutrophil migration in three dimensions: mechanical interactions between cells and matrix , 1997, Journal of leukocyte biology.

[44]  C. Morys-Wortmann,et al.  Trypsin induced von Willebrand factor release from human endothelial cells in mediated by PAR-2 activation. , 1996, Thrombosis research.

[45]  N. Christou,et al.  Shedding of L-selectin as a mechanism for reduced polymorphonuclear neutrophil exudation in patients with the systemic inflammatory response syndrome. , 1996, Archives of surgery.

[46]  D. Payan,et al.  Neutrophil rolling altered by inhibition of L-selectin shedding in vitro , 1996, Nature.

[47]  V. Yatsula,et al.  The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. , 1996, The Journal of clinical investigation.

[48]  E. Moore,et al.  Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. , 1996, The Journal of trauma.

[49]  E. Moore,et al.  Interleukin‐6 suppression of neutrophil apoptosis is neutrophil concentration dependent , 1995, Journal of leukocyte biology.

[50]  B. Strömbeck,et al.  Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. , 1995, European journal of biochemistry.

[51]  S. Brummel,et al.  Effects of endotoxin on expression of VLA integrins by human bronchoalveolar lavage macrophages , 1995, Journal of leukocyte biology.

[52]  S. Edwards Biochemistry and Physiology of the Neutrophil , 1994 .

[53]  P. Friedl,et al.  Lymphocyte locomotion in three-dimensional collagen gels. Comparison of three quantitative methods for analysing cell trajectories. , 1993, Journal of immunological methods.

[54]  B. Schleiffenbaum,et al.  Soluble L-selectin is present in human plasma at high levels and retains functional activity , 1992, The Journal of cell biology.

[55]  M. Dailey,et al.  Rapid modulation of homing receptors (gp90MEL-14) induced by activators of protein kinase C. Receptor shedding due to accelerated proteolytic cleavage at the cell surface. , 1990, Journal of immunology.

[56]  A. Freedman,et al.  Expression of the human leukocyte adhesion molecule, LAM1. Identity with the TQ1 and Leu-8 differentiation antigens. , 1990, Journal of immunology.

[57]  E. Berg,et al.  Function and regulation of the neutrophil MEL-14 antigen in vivo: comparison with LFA-1 and MAC-1. , 1989, Journal of immunology.

[58]  E. Berg,et al.  Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. , 1989, Science.

[59]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[60]  B. Overwien,et al.  Purification of human blood monocytes by hypotonic density gradient centrifugation in Percoll. , 1982, Journal of immunological methods.

[61]  W. Mohr,et al.  Polymorphonuclear granulocytes in rheumatic tissue destruction , 1981, Rheumatology International.

[62]  W. Mohr,et al.  Polymorphonuclear granulocytes in rheumatic tissue destruction , 2004, Rheumatology International.

[63]  G. D. Hunter,et al.  Essential role for proteinase-activated receptor-2 in arthritis. , 2003, The Journal of clinical investigation.

[64]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[65]  M. Cassatella Neutrophil-derived proteins: selling cytokines by the pound. , 1999, Advances in immunology.

[66]  H. Simms,et al.  Cytokine-mediated human polymorphonuclear neutrophil phagocytosis: evidence of differential sensitivities to manipulation of intracellular mechanisms. , 1996, The Journal of surgical research.

[67]  V. Yatsula,et al.  The Proteinase Activated Receptor-2 (PAR-2) Mediates Mitogenic Responses in Human Vascular Endothelial Cells Molecular Characterization and Evidence for Functional Coupling to the Thrombin Receptor , 1996 .